These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6971110)

  • 21. Combined contact and photocontact allergic dermatitis to etofenamate in flogoprofen gel.
    Sánchez-Pérez J; Sánchez TS; García-Díez A
    Am J Contact Dermat; 2001 Dec; 12(4):215-6. PubMed ID: 11753896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The biotransformation of fluproquazone in man and several animal species.
    Orwig BA; Dugger HA; Bhuta SI; Talbot KC; Schwarz HJ
    Arzneimittelforschung; 1981; 31(5a):904-11. PubMed ID: 6973984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
    Halpin RA; Ulm EH; Till AE; Kari PH; Vyas KP; Hunninghake DB; Duggan DE
    Drug Metab Dispos; 1993; 21(6):1003-11. PubMed ID: 7905377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of Transdermal Etofenamate and Diclofenac in Healthy Volunteers.
    Drago S; Imboden R; Schlatter P; Buylaert M; Krähenbühl S; Drewe J
    Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):423-429. PubMed ID: 28561421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative metabolic studies on [14C]-labelled acemetacin and indometacin in rats (author's transl)].
    Surborg KH
    Arzneimittelforschung; 1980; 30(8A):1384-91. PubMed ID: 7191305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
    Gaganis P; Miners JO; Knights KM
    Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid.
    Van Antwerpen P; Dufrasne F; Lequeux M; Boudjeltia KZ; Lessgyer I; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
    Eur J Pharmacol; 2007 Sep; 570(1-3):235-43. PubMed ID: 17610876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of etofenamate on early scald-induced edema. An experimental ultrasound study].
    Sauer T; Lehn N; Eitel F; Bauer JA
    Unfallchirurg; 1987 Aug; 90(8):391-3. PubMed ID: 3310239
    [No Abstract]   [Full Text] [Related]  

  • 29. Topical etofenamate to facilitate venipuncture.
    Gulcu N; Karaaslan K; Ugur F
    Pediatr Emerg Care; 2007 Oct; 23(10):759. PubMed ID: 18090116
    [No Abstract]   [Full Text] [Related]  

  • 30. Etofenamate levels in human serum and synovial fluid following iontophoresis.
    Bender T; Bariska J; Rojkovich B; Bálint G
    Arzneimittelforschung; 2001; 51(6):489-92. PubMed ID: 11455681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of activated gonarthrosis with etofenamate cream (Rheumon cream)].
    Gross W
    Fortschr Med; 1983 Nov; 101(43):1995-8. PubMed ID: 6654301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergic contact dermatitis to etofenamate. Cross-reaction to other nonsteroidal anti-inflammatory drugs.
    Alcántara Villar M; Pagan JA; Palacios L; Quiralte J; Ramirez M
    Contact Dermatitis; 2008 Feb; 58(2):118-9. PubMed ID: 18186756
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experience with etofenamate in sport injuries (author's transl)].
    Waterloh E; Groth KH
    Arzneimittelforschung; 1977; 27(6B):1355-7. PubMed ID: 579125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposition of remoxipride in different species. Species differences in metabolism.
    Widman M; Nilsson LB; Bryske B; Lundström J
    Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biochemical studies on etofenamate. Experimental tests in animals].
    Dell HD; Jacobi H; Wäsche B
    Arzneimittelforschung; 1977; 27(6B):1316-21. PubMed ID: 579120
    [No Abstract]   [Full Text] [Related]  

  • 37. Flufenamic acid bi-directionally modulates the transient outward K(+) current in rat cerebellar granule cells.
    Zhao ZG; Zhang M; Zeng XM; Fei XW; Liu LY; Zhang ZH; Mei YA
    J Pharmacol Exp Ther; 2007 Jul; 322(1):195-204. PubMed ID: 17405868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allergic and photoallergic contact dermartitis from etofenamate: study of 14 cases.
    Goday Buján JJ; Pérez Varela L; Piñeyro Molina F; Díaz Román T; Fonseca E
    Contact Dermatitis; 2009 Aug; 61(2):118-20. PubMed ID: 19706053
    [No Abstract]   [Full Text] [Related]  

  • 39. Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs.
    Beconi MG; Reed JR; Teffera Y; Xia YQ; Kochansky CJ; Liu DQ; Xu S; Elmore CS; Ciccotto S; Hora DF; Stearns RA; Vincent SH
    Drug Metab Dispos; 2007 Apr; 35(4):525-32. PubMed ID: 17220241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of a transcutaneous non-steroidal anti-inflammatory agent, etofenamate gel, on mixed phlogistic-induced hind paw edema and traumatic edema].
    Nakamura H; Motoyoshi S; Seto Y; Imazu C; Kadokawa T; Shimizu M
    Yakugaku Zasshi; 1983 Jun; 103(6):667-74. PubMed ID: 6655553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.